OROPHARYNX CANCER, RECURRENT
Clinical trials for OROPHARYNX CANCER, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER, RECURRENT trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy may replace chemo in head and neck cancer treatment
Disease control OngoingThis study tests whether the immunotherapy drug pembrolizumab (Keytruda) combined with radiation works better than standard chemotherapy (cisplatin) plus radiation for people with advanced head and neck cancer. About 126 participants with p16-positive cancer will be randomly assi…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Phase: PHASE2 • Sponsor: Loren Mell, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Blood test may spot hidden cancer return in throat cancer patients
Knowledge-focused OngoingThis study looks at whether a simple blood test that detects HPV DNA can find returning oropharynx cancer earlier than current methods like scans. Researchers will follow 200 patients who have finished treatment for HPV-positive oropharynx cancer. The goal is to see how accurate …
Matched conditions: OROPHARYNX CANCER, RECURRENT
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC